Speciality Medi.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0R0M01014
  • NSEID:
  • BSEID: 544738
INR
284.05
-14.9 (-4.98%)
BSENSE

May 14

BSE+NSE Vol: 20000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

20.0 k (49.25%) Volume

Shareholding (Mar 2026)

FII

0.24%

Held by 2 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

43.43%

Which are the latest news on Speciality Medi.?

13-May-2026
No latest news for Speciality Medi. found.

Why is Speciality Medicines Ltd falling/rising?

14-May-2026

As of 13-May, Speciality Medicines Ltd's stock price is rising to 298.95, reflecting a 4.97% increase after a trend reversal. Despite a recent decline over the past week, the stock has shown significant monthly growth of 83.35%, outperforming the Sensex.

As of 13-May, Speciality Medicines Ltd's stock price is rising, currently at 298.95, reflecting a change of 14.15 (4.97%) upward. This increase comes after a trend reversal, as the stock has gained following three consecutive days of decline. Despite opening the day with a loss of 4.97%, it reached an intraday high of Rs 299, indicating a recovery during the trading session.<BR><BR>The stock has shown significant performance over the past month, with an impressive increase of 83.35%, contrasting sharply with the Sensex, which has decreased by 2.91% in the same period. However, it is important to note that the stock has experienced a decline of 5.46% over the past week, which may have contributed to the initial drop at the market open.<BR><BR>Additionally, the stock's trading activity indicates a wide range of Rs 28.4 throughout the day, with a weighted average price closer to the lower end of this range. The delivery volume has notably decreased by 77.85% compared to the five-day average, suggesting a decline in investor participation. Despite these factors, the stock's ability to outperform its sector by 4.91% today and its position above longer-term moving averages indicate a positive momentum that is driving the current rise in price.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 262 Cr (Micro Cap)

stock-summary
P/E

31.00

stock-summary
Industry P/E

35

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.10

stock-summary
Return on Equity

28.31%

stock-summary
Price to Book

8.64

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Change in Management

28-Apr-2026 | Source : BSE

We hereby inform that the board in its meeting held on April 28 2026 has approved (1) Appointment of M/s. Hardik Jetani & Associates as secretarial Auditor of the Company for the Financial year 2025-26 and (2) Appointment of M/s. Rahul Mistri and Co. as internal Auditor of the Company for 3 financial years commencing from FY 2025-26 to FY 2027-28.

Board Meeting Outcome for Outcome Of Board Meeting Held On April 28 2026

28-Apr-2026 | Source : BSE

We hereby submit the Outcome of Board Meeting held on today i.e. April 28 2026.

Intimation Of Contact Details Of Key Managerial Personnel Pursuant To Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

28-Apr-2026 | Source : BSE

We hereby submit the intimation of Contact details of KMP pursuant to Regulation 30(5) of SEBI(LODR) Regulations 2025.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0.92%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.24%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
31
Industry P/E
35
Price to Book Value
8.64
EV to EBIT
29.88
EV to EBITDA
29.22
EV to Capital Employed
7.96
EV to Sales
4.56
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.64%
ROE (Latest)
28.31%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
Bollinger Bands
KST
Dow Theory
OBV
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.24%)

Promoter with highest holding

Parthkumar Babulal Goyani (21.12%)

Highest Public shareholder

Aparna Samir Thakker (7.33%)

Individual Investors Holdings

48.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Speciality Medi."
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Speciality Medi."
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Speciality Medi."
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "58.27",
          "val2": "27.52",
          "chgp": "111.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.09",
          "val2": "5.25",
          "chgp": "73.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.47",
          "val2": "0.60",
          "chgp": "-21.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "8.61",
          "val2": "2.93",
          "chgp": "193.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "15.60%",
          "val2": "19.08%",
          "chgp": "-3.48%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
58.27
27.52
111.74%
Operating Profit (PBDIT) excl Other Income
9.09
5.25
73.14%
Interest
0.47
0.60
-21.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
8.61
2.93
193.86%
Operating Profit Margin (Excl OI)
15.60%
19.08%
-3.48%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Speciality Medicines Ltd stock-summary
stock-summary
Speciality Medicines Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available